Arena: Pfizer concludes Arena Pharmaceuticals acquisition for $6.7bn
Pfizer will gain access to Arena's portfolio of various treatment candidates for gastroenterology, dermatology and cardiology. The post Pfizer concludes Arena Pharmaceuticals acquisition for $6.7bn appeared first on Pharmaceutical Technology.
Read full article »
Arena Pharmaceuticals is California-based biopharmaceutical company that develops and commercializes therapies for the treatment of immuno-inflammatory diseases.
Read more